Page last updated: 2024-10-31

metronidazole and Fournier Disease

metronidazole has been researched along with Fournier Disease in 4 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Research Excerpts

ExcerptRelevanceReference
"To evaluate Fournier's gangrene severity score index (FGSI) predictive value."1.37[Hyperbaric oxygen therapy adjunctive to surgical debridement in management of Fournier's gangrene: usefulness of a severity index score in predicting disease gravity and patient survival]. ( Abbar, M; Albouzidi, A; Ameur, A; Chafiqui, J; Ghadouane, M; Hajji, F; Ismail, TO; Janane, A, 2011)
"Fournier gangrene is a necrotizing fasciitis of the perineal and genital region, which almost exclusively affects men."1.33[Extensive Fournier gangrene. A dermatologic emergency]. ( Aschoff, R; Baldauf, A; Leike, S; Meurer, M; Wirth, MP, 2006)
"Fournier's gangrene is an aggressive form of necrotizing fasciitis of the perineal, perianal or genital regions, usually caused by a polymicrobial infection that includes virulent organisms."1.33The use of oxygen in Fournier's gangrene. ( Diab, AI; Safioleas, MC; Safioleas, PM; Stamatakos, MC, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista, N1
Fernández, MP1
Gambra, ML1
Rodríguez, L1
Janane, A1
Hajji, F1
Ismail, TO1
Chafiqui, J1
Ghadouane, M1
Ameur, A1
Abbar, M1
Albouzidi, A1
Aschoff, R1
Baldauf, A1
Leike, S1
Wirth, MP1
Meurer, M1
Safioleas, MC1
Stamatakos, MC1
Diab, AI1
Safioleas, PM1

Other Studies

4 other studies available for metronidazole and Fournier Disease

ArticleYear
[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus

2009
[Hyperbaric oxygen therapy adjunctive to surgical debridement in management of Fournier's gangrene: usefulness of a severity index score in predicting disease gravity and patient survival].
    Actas urologicas espanolas, 2011, Volume: 35, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Combined Modality Therapy; Debridement; Fournier

2011
[Extensive Fournier gangrene. A dermatologic emergency].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2006, Volume: 57, Issue:3

    Topics: Adult; Cefotaxime; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Follow-Up Stud

2006
The use of oxygen in Fournier's gangrene.
    Saudi medical journal, 2006, Volume: 27, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bandages; Debridement; Fournier Gan

2006